IDH2 and myeloproliferative disorder: Quantification of immunohistochemical staining of both tumor cells and the tumor microenvironment showed a slight tendency towards higher levels (as opposed to lower levels in the proteomic analysis) of IDH2 protein expression in MPN-AITL samples compared with R-AITL samples (p = 0.105) (Figure 2B).